Read More Analyst Color Analyst Ratings Biotech General Health Care News Mizuho Sees Compelling Risk/Reward For This Schizophrenia Stock Despite Recent Weakness By Vandana Singh May 26, 1:30 PM Yesterday, Karuna Therapeutics Inc (NASDAQ: KRTX) highlighted progress across the ongoing and planned clinical programs of KarXT, with a primary focus on the planned Phase 3 program evaluating KarXT for psychosis in Alzheimer's disease. KRTX
Read More After-Hours Center Markets Movers News Trading Ideas Apple And Disney Lead The Dow Jones Lower By Henry Khederian September 14, 4:08 PM U.S. indices were trading lower Tuesday despite better-than-expected inflation data as stocks continue to sell off following August strength. AAPL
Read More News Tech Tesla Raised Prices for All Models in the U.S. By Charles Gross June 16, 4:54 AM -Reuters https://www.reuters.com/business/autos-transportation/tesla-hikes-us-prices-across-car-models-2022-06-16/ TSLA
Read More Analyst Ratings News Price Target Keybanc Maintains Overweight on APA, Raises Price Target to $31 By Benzinga Newsdesk October 21, 4:28 AM Keybanc analyst Leo Mariani maintains APA (NASDAQ:APA) with a Overweight and raises the price target from $29 to $31. APA